Mazindol
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00579 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 23 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hypervitaminosis | KG + DL |
| 2 | proximal 16p11.2 microdeletion syndrome | KG + DL |
| 3 | obsolete hypertelorism (disease) | KG + DL |
| 4 | frontorhiny | KG + DL |
| 5 | postural orthostatic tachycardia syndrome | KG + DL |
| 6 | pentosuria | KG + DL |
| 7 | lethal polymalformative syndrome, Boissel type | KG + DL |
| 8 | insomnia (disease) | KG + DL |
| 9 | benign paroxysmal torticollis of infancy | KG + DL |
| 10 | agoraphobia | KG + DL |
| 11 | fatty liver disease | KG + DL |
| 12 | anxiety disorder | KG + DL |
| 13 | sinoatrial node disease | KG + DL |
| 14 | peripheral motor neuropathy-dysautonomia syndrome | KG + DL |
| 15 | non-alcoholic steatohepatitis | KG + DL |
| 16 | sinoatrial block | KG + DL |
| 17 | attention deficit-hyperactivity disorder | KG + DL |
| 18 | major affective disorder | KG + DL |
| 19 | frontonasal dysplasia | KG + DL |
| 20 | faciodigitogenital syndrome | KG + DL |
| 21 | variably protease-sensitive prionopathy | KG + DL |
| 22 | methylmalonate semialdehyde dehydrogenase deficiency | KG + DL |
| 23 | multiple system atrophy | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.